Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: The LIFE study

European Journal of Heart Failure

Volumn 13, Issue 4, 2011, Pages 384-391

  Okin, Peter M ^a   Oikarinen, Lasse ^b   Viitasalo, Matti ^b   Toivonen, Lauri ^b   Kjeldsen, Sverre E ^c,d   Nieminen, Markku S ^b   Edelman, Jonathan M ^e   DahlÖf, Björn ^f   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Electrocardiogram; Hypertension; Hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LOSARTAN; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATENOLOL; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 79953137317     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq224     Document Type: Article

References (31)

1. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161-186.
2. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968;75:752-759.
3. Levy D, Labib SB, Andersen KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990;81:815-820. (Pubitemid 20090377)
4. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I, Battistelli M, Bartoccini C, Porecellata C. Improved electrocardiographic diagnosis of echocar-diographic left ventricular hypertrophy. Am J Cardiol 1994;74:714-719. (Pubitemid 24298928)
5. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlöf B. Relationship of the electrocardio-graphic strain pattern to left ventricular structure and function in hypertensive patients: The LIFE Study. J Am Coll Cardiol 2001;38:514-520. (Pubitemid 32721782)
6. Okin PM, Devereux RB, Fabsitz RR, Lee ET, Galloway JM, Howard BV. Quantitative assessment of electrocardiographic left ventricular strain predicts increased left ventricular mass: The Strong Heart Study. J Am Coll Cardiol 2002;40: 1395-1400. (Pubitemid 35192862)
7. Salles G, Cardoso C, Nogueira AR, Bloch K, Muxfeldt E. Importance of the elec-trocardiographic strain pattern in patients with resistant hypertension. Hypertension 2006;48:437-442. (Pubitemid 44253738)
8. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy. J Am Coll Cardiol 1998;31:383-390. (Pubitemid 28153459)
9. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Snapinn S, Dahlöf B. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension 2004;44:48-54. (Pubitemid 38823486)
10. Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J 2005;150:161-167. (Pubitemid 41097445)
11. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90:1786-1793. (Pubitemid 24320926)
12. Verdecchia P, Reboldi G, Angeli F, Avanzini F, de Simone G, Pede S, Perticone F, Schillaci G, Vanuzzo D, Maggioni AP on behalf of the HEART Survey Study Group. Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: The HEART Survey Study. Am J Hypertens 2007; 20:997-1004. (Pubitemid 47313620)
13. Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim J-H, Jennings G, Jansky P, Chen J-H, Liu L, Gao P, Probstfield J, Teo K, Yusuf S, for the ONTARGET/TRANSCEND Investigators. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the ongoing telmisartan alone and in combination with ramipril global end point trial and the telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease. Circulation 2009;120:1380-1389.
14. Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Dahlöf B, for the LIFE Study Investigators. Electrocardio-graphic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: The LIFE Study. Circulation 2006;113:67-73. (Pubitemid 43958490)
15. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S, Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001;104:1615-1621. (Pubitemid 32947523)
16. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Leonetti G, Sarti C, Tuomilehto J, Webster J, Yodfat Y, Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension 2004;44:459-464. (Pubitemid 39281496)
17. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and prediction of major cardiovascular events: The LIFE Study. JAMA 2004; 292:2343-2349. (Pubitemid 39491918)
18. Okin PM, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, for the LIFE Study Investigators. Reduction of electrocardiographic left ventricular hypertrophy is associated with decreased heart failure hospitaliz-ation in hypertensive patients. Ann Intern Med 2007;147:311-319. (Pubitemid 351664558)
19. Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB. Prognostic value of changes in the electro-cardiographic strain pattern during antihypertensive treatment: the LIFE study. Circulation 2009;119:1183-1891.
20. Okin PM, Devereux RB, Harris KE, Kjeldsen SE, Edelman JM, Dahlöf B. Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study. J Hypertens 2009;27:2271-2277.
21. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003. (Pubitemid 34286536)
22. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE study group. The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study: rationale, design, and methods. Am J Hypertens 1997;10:705-713. (Pubitemid 27313815)
23. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995;25:417-423.
24. Kannel WB, D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PWF, Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999;159:1197-1204. (Pubitemid 29269859)
25. Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE Study. J Hypertension 2006;24:2079-2084. (Pubitemid 44371275)
26. Russo C, Jin Z, Homma S, Rundek T, Elkind MSV, Sacco RL, Di Tullio MR. Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail 2010;12:454-461.
27. Rembert JC, Kleinman LH, Fedor JM, Wechsler AS, Greenfield JC Jr. Myocardial blood flow distribution in concentric left ventricular hypertrophy. J Clin Invest 1978;62:379-386. (Pubitemid 8393308)
28. O'Keefe JH, Owen RM, Bove AA. Influence of left ventricular mass on coronary artery cross-sectional area. Am J Cardiol 1987;59:1395-1397. (Pubitemid 17093828)
29. Anderson HV, Stokes MJ, Leon M, Abu-Halawa SA, Stuart Y, Kirkeeide RL. Coronary flow velocity in related to lumen area and regional left ventricular mass. Circulation 2000;102:48-54. (Pubitemid 30430552)
30. Okin PM, Roman MJ, Lee ET, Galloway JM, Howard BV, Devereux RB. Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: The Strong Heart Study. Hypertension 2004;43:769-774. (Pubitemid 38405585)
31. Dahlstrom U, Hakansson J, Swedberg K, Waldenstrom A. Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden. Eur J Heart Fail 2009;11:92-98.